CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.

S Devereux; J E Parker; T Shafi; A Pagliuca; E Macdonald; G J Mufti

CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.

S Devereux, J E Parker, T Shafi, A Pagliuca, E Macdonald, G J Mufti

King's College London

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	355B - 356B
Journal	Blood
Volume	98
Issue number	11
Publication status	Published - 2001

Cite this

Devereux, S., Parker, J. E., Shafi, T., Pagliuca, A., Macdonald, E., & Mufti, G. J. (2001). CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression. Blood, 98(11), 355B - 356B.

@article{f1da0e95b3144b8db1ccdfc239232516,

title = "CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.",

author = "S Devereux and Parker, {J E} and T Shafi and A Pagliuca and E Macdonald and Mufti, {G J}",

year = "2001",

language = "English",

volume = "98",

pages = "355B -- 356B",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

Devereux, S, Parker, JE, Shafi, T, Pagliuca, A, Macdonald, E & Mufti, GJ 2001, 'CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.', Blood, vol. 98, no. 11, pp. 355B - 356B.

CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression. / Devereux, S; Parker, J E; Shafi, T et al.
In: Blood, Vol. 98, No. 11, 2001, p. 355B - 356B.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.

AU - Devereux, S

AU - Parker, J E

AU - Shafi, T

AU - Pagliuca, A

AU - Macdonald, E

AU - Mufti, G J

PY - 2001

Y1 - 2001

M3 - Meeting abstract

SN - 1528-0020

VL - 98

SP - 355B - 356B

JO - Blood

JF - Blood

IS - 11

ER -